CAI Spring Webinar Series - Two sides of the coin: A patient/provider dyad explore diagnostic error and the benefits of CRP
April 15, 2021 –
- Understand the individual and system factors that can cause diagnostic errors
- Explore the benefits of a CRP response following a diagnostic error
- Examine the consequences of a poor response to a diagnostic error
- Understand the importance of engaging, listening, and learning from patients and families following diagnostic errors
Eric J. Thomas, MD, MPH Board President, Collaborative for Accountability and Improvement; Associate Dean for Healthcare Quality, McGovern Medical School, University of Texas Health Science Center at Houston
Eric J. Thomas, M.D., M.P.H. is a Professor of Medicine and Associate Dean for Healthcare Quality at the McGovern Medical School at The University of Texas Health Science Center at Houston. He also directs the UT Houston-Memorial Hermann Center for Healthcare Quality and Safety. Since 1992 he has conducted research on patient safety and his work was heavily cited in the Institute of Medicine’s reports To Err is Human (2000), and Improving Diagnosis in Health Care (2015). Dr. Thomas’ current research focuses on topics such as diagnostic errors, measuring safety culture, and engaging families and frontline clinicians in detecting harm and improving patient safety.
Suzanne Schrandt, JD, Founder, CEO, & Chief Patient Advocate at ExPPect
Suz Schrandt is a patient advocate and patient engagement expert with a health and disability policy background. She is the Founder and CEO of ExPPect, a patient engagement initiative focused on improving healthcare and research through the expertise and partnership of patients, and she serves as the Senior Patient Engagement Advisor to the Society to Improve Diagnosis in Medicine. Schrandt previously served as Deputy Director of Patient Engagement for the Patient-Centered Outcomes Research Institute (PCORI), and as the Director of Patient Engagement for the Arthritis Foundation. Her career spans work in health reform, bioethics, genetic discrimination, and chronic disease self-management, as well as a long history in patient-led health professions education. Schrandt is one of nine voting members on the FDA’s inaugural Patient Engagement Advisory Committee, the Chairperson for the International Society of Pharmacoeconomics and Outcomes Research Global Patient Council, and has been an invited speaker at numerous US and international conferences. Schrandt received her law degree from the University of Kansas and has co-authored multiple peer-reviewed articles on health policy and the value of patient engagement.